102373-23-9

Basic information

• Product Name: Cyclohexanecarboxylic acid, 1-amino-, phenylmethyl ester
• CAS NO: 102373-23-9
• Molecular Formula: C14H19NO2
• Molecular Weight: 233.31
• Mol File: 102373-23-9.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Cyclohexanecarboxylic acid, 1-amino-, phenylmethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Cyclohexanecarboxylic acid, 1-amino-, phenylmethyl ester(102373-23-9)
• EPA Substance Registry System: Cyclohexanecarboxylic acid, 1-amino-, phenylmethyl ester(102373-23-9)

Safety Data

• Hazardous Substances Data: 102373-23-9(Hazardous Substances Data)

Upstream product

• 102373-24-0 1-aminocyclohexanecarboxylic acid benzyl ester p-toluenesulfonate 
• 2756-85-6 1-aminocyclohexane carboxylic acid 
• 100-51-6 benzyl alcohol 
• 468762-35-8 benzyl 1-((tert-butoxycarbonyl)amino)cyclohexane-1-carboxylate 

Downstream Products

• 467443-23-8 1-[3-(3,4-dichloro-benzyl)-ureido]-cyclohexanecarboxylic acid benzyl ester 
• 467443-18-1 1-[3-(4-chloro-phenyl)-ureido]-cyclohexanecarboxylic acid benzyl ester 
• 467443-19-2 1-[3-(3,4-dichloro-phenyl)-ureido]-cyclohexanecarboxylic acid benzyl ester 
• 274685-77-7 phenylmethyl 1-[N-[4-(2-methyl-2-propyloxycarbonyl)piperazine-1-carbonyl]amino]cyclohexanecarboxylate 
• 944282-05-7 1-[(2-benzothienylcarbonyl)amino]cyclohexanecarboxylic acid phenylmethyl ester 
• 944282-15-9 1-[[[4-[2-(4-methyl-1-piperazinyl)-4-thiazolyl] phenyl] carbonyl] amino] cyclohexanecarboxylic acid phenylmethyl ester 
• 236123-25-4 benzyl [(S)-1-[N-tert-butyldimethylsilyl-4-oxo-azetidine-2-carbonyl]amino]cyclohexanecarboxylate 
• 944281-99-6 N-[[1-[[(Phenylmethoxy)carbonyl]amino]cyclohexyl]carbonyl]-L-valinal 
• 944281-90-7 N-[[1-[[(phenylmethoxy)carbonyl]amino]cyclohexyl]carbonyl]-L-valinol 
• 944282-17-1 2-[4-[2-(4-methyl-1-piperazinyl)-4-thiazolyl]phenyl]-3-oxa-1-azaspiro[4.5]dec-1-en-4-one 

Relevant articles and documents

COMBINATIONS OF HEPATITIS C VIRUS INHIBITORS

The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.

PEPTIDIC COMPOUNDS

The present invention provides a compound of formula (I), (II), (III) and (IV) as defined herein and pharmaceutically acceptable derivatives thereof. The present invention further provides use of the compounds of the present invention in the treatment of bacterial infection and in the treatment of HIV infection. Also provided are pharmaceutical compositions comprising the compounds of the present invention.